{"disease":{"id":"chronic-cutaneous-ulcer","name":"chronic cutaneous ulcer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03038672","title":"Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":54,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04058197","title":"Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"TauTona Group","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}